🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

More Realistic Spine Patients: Assessing the Effect of Dialogue Support Tool.

RecruitingNAAges 18 Years - anyAllUniversity Hospital, Akershus
NCT07788872 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This multicenter randomized controlled trial will evaluate whether an additional preoperative study visit using the Dialogue Support (DS) tool improves patient information, expectations, and outcomes among adults scheduled for lumbar spine surgery for degenerative spinal disorders. The DS tool predicts outcomes one year after surgery based on patient characteristics and presents these estimates numerically and visually. Participants will be randomized to either one additional study visit in which DS results are presented and explained, or a control study visit during which DS will not be employed The study will assess whether the additional DS study visit influences postoperative outcomes, preoperative expectations, surgery cancellations, and cost-effectiveness. In addition, the project will externally validate the DS tool using data from the Norwegian Registry for Spine Surgery (NORspi

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Patients scheduled to undergo lumbar spinal surgery for: * Disc herniation * Spinal stenosis * Degenerative disc disease. Exclusion Criteria: * Patients who do not understand spoken or written Norwegian will be excluded, as language barriers may interfere with the intervention consultation, comprehension of the information provided, and completion of study questionnaires. * Patients with spondylolysis or lytic spondylolisthesis * Patients already participating in other clinical studies.
💊

What it tests

  • Dialogue Support Study Visit
📍

Where

2 sites
Akershus University Hospital
Oslo, Norway
Innlandet Hospital Trust.
Gjøvik, Norway
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy